Timeline of the Development of Skin-Lightening Active Ingredients in Japan
Author:
Open Access
Abstract
Japanese pharmaceutical cosmetics, often referred to as quasi-drugs, contain skin-lightening active ingredients formulated to prevent sun-induced pigment spots and freckles. Their mechanisms of action include suppressing melanin production in melanocytes and promoting epidermal growth to eliminate melanin more rapidly. For example, arbutin and rucinol are representative skin-lightening active ingredients that inhibit melanin production, and disodium adenosine monophosphate and dexpanthenol are skin-lightening active ingredients that inhibit melanin accumulation in the epidermis. In contrast, oral administration of vitamin C and tranexamic acid in pharmaceutical products can lighten freckles and melasma, and these products are more effective than quasi-drugs. On the basis of their clinical effectiveness, skin-lightening active ingredients can be divided into four categories according to their effectiveness and adverse effects. This review discusses academic research and development regarding skin-lightening ingredients in Japan.Keywords
This publication has 76 references indexed in Scilit:
- Topical 5% tranexamic acid for the treatment of melasma in Asians: A double-blind randomized controlled clinical trialJournal of Cosmetic and Laser Therapy, 2012
- Allergic contact dermatitis caused by a skin‐lightening agent, 5,5′‐dipropylbiphenyl‐2,2′‐diolContact Dermatitis, 2011
- A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of MelasmaDermatology Research and Practice, 2011
- The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face TrialAnnals of Dermatology, 2010
- Inhibitory Effect of Ascorbic Acid 2-O-.ALPHA.-Glucoside on the Pigmentation of Skin by Exposure to Ultraviolet Light.The Nishinihon Journal of Dermatology, 1996
- Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivoJournal of the American Academy of Dermatology, 1996
- Clinical evaluation for a chloasma of a cream mixed with oil soluble Kanzo extract (glycyrrhiza ext.).The Nishinihon Journal of Dermatology, 1995
- Clinical evaluation result on protective effect for pigmentation by ultraviolet irradiation of XSC-29 pharmaceutical.The Nishinihon Journal of Dermatology, 1995
- Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: A vehicle-controlled trialJournal of the American Academy of Dermatology, 1994
- Tretinoin emollient cream: A new therapy for photodamaged skinJournal of the American Academy of Dermatology, 1992